Coronary Intervention & Surgery

Intravenous nicorandil cut the risk of periprocedural myocardial injury (pMI) after percutaneous coronary intervention (PCI) by 49 percent among patients 65 and older, according to a substudy of a randomized trial published in PLOS One.
Nearly one in 10 patients who receive percutaneous coronary intervention (PCI) end up back in the hospital with an unplanned readmission within 30 days, according to a study published online April 2 in JACC: Cardiovascular Interventions. These readmissions are usually for noncardiac causes and heavily linked to a patient’s comorbidities and place of discharge, the researchers found.
A hybrid revascularization approach combining PCI and coronary artery bypass grafting (CABG) produced similar five-year outcomes compared to CABG alone, according to a randomized trial of patients with multivessel coronary artery disease (CAD) published in JACC: Cardiovascular Interventions.
A country-wide examination of data in France showed a marked increase in transcatheter aortic valve replacement (TAVR) procedures, in addition to reduction in in-hospital mortality for all AVR subsets.
Apr 10, 2018 | Healthcare Economics
The expansion of Medicaid eligibility in Michigan allowed more patients to get coronary revascularization procedures without negatively affecting patient outcomes, suggests a research letter published in the Journal of the American College of Cardiology.
About 3 percent of patients undergoing transcatheter aortic valve replacement (TAVR) also have severe mitral stenosis and are at a greater risk of long-term adverse events, researchers reported in JACC: Cardiovascular Interventions.
Victor Gurewich, MD, has spent more than two decades trying to spread the word about what he sees as an effective, lifesaving treatment approach to heart attack and stroke. At 88 years old, the cardiologist is hoping to breakthrough soon—and a new clinical trial in Europe could help.
A genetic test to inform decisions about what antiplatelet to use following percutaneous coronary intervention (PCI) significantly reduced the number of major cardiovascular or cerebrovascular events in a single-center study published in Circulation: Genomic and Precision Medicine.
Sutureless valves have recently been developed to streamline surgical aortic valve replacement (SAVR) procedures, with the hope that shorter operations lead to better outcomes. But a new study in the Journal of the American College of Cardiology suggests quicker is not always better.
Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.
Bioprosthetic heart valves used in surgical aortic valve replacement (SAVR) procedures in the early 2000s demonstrated “satisfactory” durability, according to a single-center study published in the Journal of the American College of Cardiology.
Lesbian, gay and bisexual adults are likely to have poor cardiovascular health compared to heterosexual counterparts, according to findings presented March 20 at the American Heart Association’s Epidemiology and Lifestyle conference in New Orleans.
The higher rates of all-cause mortality after percutaneous coronary intervention (PCI) observed in women can be attributed to noncardiac factors, suggests a single-center study published in Circulation: Cardiovascular Interventions.
There are few significant differences in target-vessel failure with second generation drug-eluting stents (DES) for patients with left main coronary artery disease (LMCAD), according to research published on Feb. 27 in the Journal of the American College of Cardiology.
Patients hospitalized with acute myocardial infarction (AMI) actually fare better when some of the top minds in interventional cardiology are away at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting, suggests a study published March 9 in the Journal of the American Heart Association.
There is a small but significant long-term survival benefit of on-pump coronary artery bypass graft (CABG) surgery when compared to off-pump procedures, according to a meta-analysis published online Feb. 26 in the Journal of the American College of Cardiology.
Roughly one-third of patients without known diabetes in a PCI trial had abnormal glucose readings and demonstrated up to a four-fold risk of adverse outcomes within one year, researchers reported in JACC: Cardiovascular Interventions.
The FDA has approved Medtronic's two-millimeter Resolute Onyx drug-eluting stent (DES), making it the smallest DES on the U.S. market.
The American College of Cardiology has recognized Melissa Cappuccilli, a nurse and single mother of four who received a heart transplant in 2013, as a part of its “I am CardioSmart” contest.
Coronary artery bypass grafting (CABG) is preferred to percutaneous coronary intervention for patients with diabetes and coronary artery disease (CAD). But new research showed CABG outperformed PCI when focusing specifically on individuals with left ventricular dysfunction (LVD), a population that had been excluded in past studies.
New-onset atrial fibrillation (NOAF) occurred in 18 percent of patients undergoing coronary artery bypass grafting (CABG) but just 0.1 percent of those receiving PCI, according to an analysis of the international EXCEL trial published in the Journal of the American College of Cardiology. What’s more, the patients who developed NOAF within a few days of surgery were at a 3.02-fold risk of death and a 4.19-fold risk of suffering a stroke over the following three years.